Preterm infants (gestational age (GA) at birth \< 31 weeks) admitted to the University of Minnesota Masonic Children's Hospital NICU will have a Dexcom G6 sensor Continuous Glucose Monitor (CGM) placed shortly after consent and wear the device for up to 10 days. The low alarm threshold will be set at 60 mg/dL or 80mg/dL (depending on whether they are receiving continuous insulin) to detect the potential for hypoglycemia. A suggestion will be made to the clinical team to draw a blood glucose to correlate with CGM values ≤60 mg/dL and the infant will be treated according to Neonatal Intensive Care Unit (NICU) protocol for corroborating blood glucose levels. Infants will also be monitored per current NICU protocol (blood glucose checks every 1-2 hours while on insulin) and treated accordingly. Clinical data and long-term growth, body composition and neurodevelopmental outcomes will be recorded.
Study Type
OBSERVATIONAL
Enrollment
24
The device used as part of the study is to obtain results for glucose testing for research only and not for diagnostic purposes.
University of Minnesota
Minneapolis, Minnesota, United States
Detection of hypo- and hyperglycemia - CGM device
Proportion of CGM device readings that match blood glucose readings
Time frame: 10 days post placement of CGM
Detection of hypo- and hyperglycemia - 60 mg/dL
% time below 60 mg/dL
Time frame: 10 days post placement of CGM
Detection of hypo- and hyperglycemia - 180 mg/dL
% time above 180 mg/dL
Time frame: 10 days post placement of CGM
Detection of hypo- and hyperglycemia - AEs
% of infants with adverse events secondary to CGM placement or wear
Time frame: 10 days post placement of CGM
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.